These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6645322)

  • 1. [Mechanism of the nephrotoxic action of aminoglycoside antibiotics].
    Sigulia EE
    Klin Med (Mosk); 1983 Oct; 61(10):18-9. PubMed ID: 6645322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ototoxic drugs. I. Aminoglycoside antibiotics].
    Buszman E; Wrześniok D; Matusiński B
    Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminoglycosides, risk factors and neonatal kidney].
    Khoory BJ; Fanos V; Dall'Agnola A; Cataldi L
    Pediatr Med Chir; 1996; 18(5):495-9. PubMed ID: 9053889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 2.
    Peloquin C
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2750-1; author reply 2752. PubMed ID: 20480959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemical basis of the nephrotoxic effect of aminoglycoside antibiotics].
    Michalik M
    Postepy Biochem; 1991; 37(2):92-103. PubMed ID: 1819800
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible mechanism for increased susceptibility to aminoglycoside nephrotoxicity in chronic renal disease.
    Riviere JE
    N Engl J Med; 1982 Jul; 307(4):252-3. PubMed ID: 7088081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of sodium nucleinate and its combinations with bacterial polysaccharides for preventing the nephrotoxic action of aminoglycoside antibiotics].
    Salakaia RG; Amirian NB
    Antibiotiki; 1984 Jul; 29(7):507-9. PubMed ID: 6486749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Search for new methods of administering aminoglycoside antibiotics to attenuate side effects].
    Nowak P
    Postepy Hig Med Dosw; 2000; 54(5):571-83. PubMed ID: 11146886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomorphological aspects of the action of aminoglycoside antibiotics on the acoustic analyzer].
    Zhuravskiĭ SG; Tomson VV; Tsvyleva ID; Ivanov AG
    Vestn Otorinolaringol; 2003; (2):55-60. PubMed ID: 12958868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenetic heterogenicity of ototoxic complications caused by aminoglycoside antibiotics].
    Zhuravskiĭ SG; Setkhiiaasiilan T; Dekhtiareva IuA
    Vestn Otorinolaringol; 2005; (1):62-5. PubMed ID: 15700018
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aminoglycoside nephrotoxicity and obstructive jaundice].
    Lucena MI; Andrade RJ
    Med Clin (Barc); 1995 Oct; 105(12):457-60. PubMed ID: 7490937
    [No Abstract]   [Full Text] [Related]  

  • 13. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside therapy.
    Magnussen MH
    Nursing; 1980 Feb; 10(2):82-8. PubMed ID: 6898900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early detection of the nephrotoxic effect of aminoglycosides].
    Tenerowicz R; Sułowicz W
    Przegl Lek; 1990; 47(7):565-7. PubMed ID: 2284426
    [No Abstract]   [Full Text] [Related]  

  • 16. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
    Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
    Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes: a risk factor in aminoglycoside nephrotoxicity.
    Rush DS; DiPiro JT; Record KT; Bivins BA
    Curr Surg; 1982; 39(4):244-7. PubMed ID: 7116917
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitization to antibiotics of the aminoglycoside group].
    Van Joost T; Boelen RE; Faber WR
    Ned Tijdschr Geneeskd; 1981 Apr; 125(15):572-5. PubMed ID: 6454079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.